These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 6981541)

  • 21. T cell receptor repertoire in B cell lymphoproliferative lesions in primary Sjögren's syndrome.
    Pivetta B; De Vita S; Ferraccioli G; De Re V; Gloghini A; Marzotto A; Caruso G; Dolcetti R; Bartoli E; Carbone A; Boiocchi M
    J Rheumatol; 1999 May; 26(5):1101-9. PubMed ID: 10332975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antineoplastic agents and biologic response modifiers in oncologic hematology].
    Cabrera Marín JR; Briz del Blanco M
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():3-13. PubMed ID: 10422445
    [No Abstract]   [Full Text] [Related]  

  • 23. Twenty-first century Foxp3.
    O'Garra A; Vieira P
    Nat Immunol; 2003 Apr; 4(4):304-6. PubMed ID: 12660726
    [No Abstract]   [Full Text] [Related]  

  • 24. Polymorphism and T-cell infiltration in posttransplant lymphoproliferative disorders.
    Minervini MI; Swerdlow SH; Nalesnik MA
    Transplant Proc; 1999; 31(1-2):1270. PubMed ID: 10083566
    [No Abstract]   [Full Text] [Related]  

  • 25. A lymphotactin-producing monoclonal T-cell lymphoproliferative disorder with extreme lymphocytopenia and progressive leukoencephalopathy.
    Visentini M; Carbonari M; Ghia E; De Propriis S; Guarini A; Girmenia C; Giannini G; Sabattini E; Ceccarini C; Zamarchi R; Giangaspero F; Novelli A; Amadori A; Pileri SA; Fiorilli M
    Leuk Lymphoma; 2006 Jul; 47(7):1421-3. PubMed ID: 16923584
    [No Abstract]   [Full Text] [Related]  

  • 26. Progressive multifocal leukoencephalopathy after fludarabine therapy for low-grade lymphoproliferative disease.
    Vidarsson B; Mosher DF; Salamat MS; Isaksson HJ; Onundarson PT
    Am J Hematol; 2002 May; 70(1):51-4. PubMed ID: 11994982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired T cell functions preceding lymphoproliferative disorders in mice neonatally tolerized to transplantation antigens.
    Jánossy T; Vizler C; Ocsovszki I; Tibbe GJ; Pipis J; Savelkoul HF; Végh P; Benner R
    Acta Chir Hung; 1997; 36(1-4):150-1. PubMed ID: 9408323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical analysis of 52 patients with granular lymphocyte proliferative disorder (GLPD) showed frequent anemia in indolent T-cell GLPD in Japan.
    Kawahara S; Sasaki M; Isobe Y; Ando J; Noguchi M; Koike M; Hirano T; Oshimi K; Sugimoto K
    Eur J Haematol; 2009 Apr; 82(4):308-14. PubMed ID: 19220421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new form of T-cell PTLD.
    Litz C; Hanson M
    Am J Clin Pathol; 2000 Apr; 113(4):598. PubMed ID: 10761467
    [No Abstract]   [Full Text] [Related]  

  • 30. Induction of neonatal transplantation tolerance and lymphoproliferative disorders in mice: the role of F1 donor cells.
    Jánossy T; Baranyi L; Vizler C; Nyirati I; Végh P
    Transplant Proc; 1995 Feb; 27(1):188-90. PubMed ID: 7878968
    [No Abstract]   [Full Text] [Related]  

  • 31. T-cell post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation: another case and a review of the literature.
    Lau LG; Tan LK; Salto-Tellez M; Koay ES; Liu TC
    Bone Marrow Transplant; 2004 Nov; 34(9):821-2. PubMed ID: 15354208
    [No Abstract]   [Full Text] [Related]  

  • 32. Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders.
    Sebti Y; Le Maux A; Gros F; De Guibert S; Pangault C; Rouas-Freiss N; Bernard M; Amiot L
    Br J Haematol; 2007 Jul; 138(2):202-12. PubMed ID: 17593027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical pharmacology of 2-chlorodeoxyadenosine (Cladribine)].
    Góra-Tybor J; Robak T
    Przegl Lek; 1996; 53(8):614-8. PubMed ID: 8999463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes.
    Bosque A; Aguiló JI; del Rey M; Paz-Artal E; Allende LM; Naval J; Anel A
    J Leukoc Biol; 2008 Aug; 84(2):488-98. PubMed ID: 18483205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle.
    Sokol H; Beaugerie L
    Gut; 2009 Oct; 58(10):1427-36. PubMed ID: 19749141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells.
    Markasz L; Stuber G; Flaberg E; Jernberg AG; Eksborg S; Olah E; Skribek H; Szekely L
    BMC Cancer; 2006 Nov; 6():265. PubMed ID: 17101045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric assessment of TCR-Vbeta expression in the evaluation of peripheral blood involvement by T-cell lymphoproliferative disorders: a comparison with conventional T-cell immunophenotyping and molecular genetic techniques.
    Morice WG; Kimlinger T; Katzmann JA; Lust JA; Heimgartner PJ; Halling KC; Hanson CA
    Am J Clin Pathol; 2004 Mar; 121(3):373-83. PubMed ID: 15023042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Granular lymphocyte-proliferative disorders, lymphoproliferative disease of granular lymphocytes].
    Egashira M; Oshimi K
    Ryoikibetsu Shokogun Shirizu; 2000; (32):547-9. PubMed ID: 11212801
    [No Abstract]   [Full Text] [Related]  

  • 39. Introduction to lymphoproliferative disorders in adults.
    Leclair SJ; Ferreira K
    Clin Lab Sci; 2013; 26(4):181. PubMed ID: 24432510
    [No Abstract]   [Full Text] [Related]  

  • 40. Skewed expression of natural-killer (NK)-associated antigens on lymphoproliferations of large granular lymphocytes (LGL).
    Fischer L; Hummel M; Burmeister T; Schwartz S; Thiel E
    Hematol Oncol; 2006 Jun; 24(2):78-85. PubMed ID: 16598823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.